吉林大学学报(医学版) ›› 2013, Vol. 39 ›› Issue (1): 138-142.doi: 10.7694/jldxyxb20130131

• 基础研究 • 上一篇    下一篇

帕瑞昔布钠用于肾移植术后患者的镇痛效果及其安全性评价

严进军,庞 磊,董 愫,冯艳华,麻海春   

  1. 吉林大学第一医院麻醉科,吉林 长春 130021
  • 收稿日期:2012-09-27 出版日期:2013-01-28 发布日期:2013-01-30
  • 通讯作者: 麻海春(Tel:0431-88783337,E-mail:polly_sd@sina.com) E-mail:polly_sd@sina.com
  • 作者简介:严进军(1986-),男,四川省达州市人,在读医学硕士,主要从事麻醉对移 植肾功能影响方面的研究。
  • 基金资助:

    吉林省科技厅国际合作项目资助课题(20110759)

Effect of parecoxib sodium on postoperative analgesia in 
 patients after renal transplantation and evaluation on its security

YAN Jin-jun,PANG Lei,DONG Su,FENG Yan-hua,MA Hai-chun   

  1. Department of Anesthesiology,First Hospital,Jilin University,Changchun 130021,China
  • Received:2012-09-27 Online:2013-01-28 Published:2013-01-30

摘要: 目的:探讨帕瑞昔布钠用于肾移植术后患者的镇痛效果和安全性,为肾移植患者术
后镇痛药物的使用提供临床依据。方法:选择行同种异体肾移植术患者48例,随机分为帕瑞
昔布组、芬太尼组和对照组,每组16例。分别在停用麻醉药前10 min通过静脉给予患者帕瑞
昔布40 mg、芬太尼0.1 mg和生理盐水2 mL。观察各组患者拔管前5 min(T1)、拔管即刻
(T2)、拔管后5 min(T3)、拔管后10 min(T4)血流动力学变化,同时记录患者有无呛咳
、恶心及呕吐,评价患者镇静和镇痛评分。比较3组患者术前、术后12 h、术后36 h尿量及
血清肌酐(SCr) 、尿素氮(BUN)水平。结果: 3组患者手术时间、术中输液量和住院天
数比较差异均无统计学意义(P>0.05)。与T1时间点比较,对照组患者在T2、T3和T4
时间点收缩压(SBP)水平均升高(P<0.05);与T1时间点比较,芬太尼组患者在T3、T4时间点
血氧饱和度(SpO2)水平降低(P<0.05);而帕瑞昔布钠组患者的血流动力学指标在T1、T2、T3和
T4时间点比较差异均无统计学意义(P>0.05)。与对照组比较,帕瑞昔布钠组和芬太尼组患者呛
咳躁动的发生率明显降低(P<0.05);3组患者恶心及呕吐的发生率组间比较差异均无统计学意
义(P>0.05);与对照组比较,帕瑞昔布钠组和芬太尼组术后镇痛药曲马多的使用次数减少;术前、术后3组患者的
尿量、血清BUN和SCr水平比较差异均无统计学意义 (P>0.05)。在术后镇痛方面,芬太
尼组患者术后镇痛评分与对照组比较差异无统计学意义(P>0.05);帕瑞昔布钠组患者术后镇痛评分低于
其他2组,差异有统计学意义(P<0.05)。在术后镇静方面,芬太尼组患者术后镇静评分低
于其他2组(P<0.05)。结论:帕瑞昔布钠静脉注射可以用于肾移植术后镇痛和镇静,副作用相对较小。

关键词: 帕瑞昔布钠, 肾移植, 术后疼痛, 术后镇痛, 血流动力学

Abstract: Abstract:Objective To determine the effect and safety of parecoxib sodium on pos
toperative analgesia in patients after renal transplantation,and to provide basi
s for application of analgesia medicine for patients after renal transplantation.
Methods Forty-eight patients underwent renal allogeneic transplantation were randomly
divided into parecoxib sodium group,fentanyl group,and control group,and there
were 16 patients in each group.The patients in three groups were given parecoxib
 sodium 40 mg,fentanyl 0.2 mg and saline 2 mL,respectively.The hemodynamic  parameters of patients in various groups were recorded at  5 min before e
xtubation(T1),extubation time(T2),5 min after extubation(T3) and 10 min after extubation(T4);and the occurrence of  cough,nausea and vomiting of patients
 were recorded;the postoperative pain and sedation levels were evaluated;the urine output,the levels of serum creatinine(SCr) and blood urea nitrogen (BUN) of
 patients in various groups before operation and 12,36 h after operation were compared.
Results There were no significant differences of operation time,intraoperative
infusion amount and hospitalization time of patients between various groups (P> 0.05).
Compared with T1 time point,the  SBP  levels of patients at T2,T3 and T4 in control group were increased(P<0.05);compared with T1 time point,the levels of oxygen sa
turation (SpO2)of patients at T3 and T4 in fentanyl group were decreased(P<0.05).There were no significant differences of
hemodynamic parameters of patients in parecoxib sodium group at T1,T2,T3 and T4 time points(P> 0.05).
Compared with control group,the incidence rates of tussis and dysphoria of patients in parecoxib sodium group and fentanyl
 group were decreased(P<0.05);there were no siginificant differences of the incidence rates of nausea and vomiting between var
ious groups(P>0.05).Compared with control group,the using times of tramadol hydrochloride  of patients in parecoxib sodium
group and fentanyl group were decreased.There was also no siginificant difference of urine volume,serum BUN,and SCr of
 patients between  various groups before and after operation (P>0.05).There was also  no siginificant difference of postoperative analgesia between fentanyl group and control group(P>0.05).The scores of postoperative analgesia of patients in parecoxib sodium group were lower than those in the other groups(P<0.05);the scores of postoperative sedation of patients in fentanyl group was lower than those in the other groups(P<0.05).
Conclusion Parecoxib sodium can be a candidate drug for postoperative  pain relief in patients underwent  renal transplantation,which has fewer side effects.

Key words: parecoxib sodium, renal transplantation, postoperative pain, postoperative analgesia, hemodynamics

中图分类号: 

  • R614